Chugai Pharma Manufacturing Co. Ltd.September 1, 2017

FDA 483 - Chugai Pharma Manufacturing Co. Ltd. - September 01, 2017

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chugai Pharma Manufacturing Co. Ltd.

Record Details

An FDA inspection of Chugai Pharma Manufacturing Co., Ltd. in Utsunomiya City, Japan, revealed several significant deficiencies in their manufacturing and quality control processes. Observations included inadequate smoke studies for filling lines, insufficient quality assurance oversight, and failures in deviation management. The firm also had issues with the validation of its electronic Manufacturing Execution System and non-compliance with pest control procedures.

Company: Chugai Pharma Manufacturing Co. Ltd.
Inspection Date: September 1, 2017
Product Type: Drugs
Office: International Compliance Team
People: Aimee Cunningham (issuing_officer)
Marion Michaelis

Open in Dashboard

ID · ee577c44-8836-4d26-b356-0b0995835728